DUO-O
DUO-O: First-line CT + Bevacizumab ± Durvalumab Followed by Maintenance Bevacizumab ± Durvalumab With or Without Olaparib in Newly Diagnosed Advanced Ovarian Cancer Without Tumor BRCA Mutation

Released: June 07, 2023

Activity

Progress
1
Course Completed